Community HIV treatment advocacy programs may support treatment adherence.

Community HIV treatment advocacy programs may support treatment adherence.
复制标题

DOI:
10.1521/aeap.2012.24.1.1
复制
发表时间:
2012-02
期刊:
AIDS education and prevention : official publication of the International Society for AIDS Education
影响因子:
--
通讯作者:
Klein DJ
Klein DJ
中科院分区:
其他
文献类型:
--
作者:
Bogart LM;Wagner GJ;Mutchler MG;Risley B;McDavitt BW;McKay T;Klein DJ

文献摘要

参考文献

被引文献

相似文献

治疗倡导(TA)计划以艾滋病服务组织和诊所为基础,旨在通过以客户为中心的咨询,让客户参与护理并支持抗逆转录病毒治疗(ART)的坚持;为患者和提供者辩护;并提供社会服务转介。缺乏对TA的系统评价。我们对 121 名 HIV 阳性患者(36 名 TA,85 名非 TA;87% 男性,34% 非裔美国人,31% 白人,19% 拉丁裔)进行了非随机评估,检查 TA 参与与依从性、护理参与度、社会服务利用、未满足需求、患者自我倡导和依从自我效能的关系。在多变量模型中,TA 参与者(与非 TA 参与者相比)表现出更高的电子监测水平 [服用剂量的 85.3% vs. 70.7%; b(SE)=13.16(5.55), p<.05] 和自我报告 [91.1% vs. 75.0%; b(SE)=11.60(5.65), p<.05] 依从性;利用更多的社会服务计划 [Ms = 5.2 vs. 3.4; b(SE)=1.97(0.48),p<.0001];未满足的社会服务需求较少 [Ms = 1.8 vs. 2.7; b(SE)=−1.06(0.48),p<.05]。研究结果表明需要对 TA 进行随机对照试验。
Treatment advocacy (TA) programs, based in AIDS service organizations and clinics, aim to engage clients into care and support antiretroviral treatment (ART) adherence through client-centered counseling; advocate for patients with providers; and provide social service referrals. Systematic evaluations of TA are lacking. We conducted a non-randomized evaluation examining relationships of TA participation to adherence, care engagement, social services utilization, unmet needs, patient self-advocacy, and adherence self-efficacy among 121 HIV-positive clients (36 in TA, 85 not in TA; 87% male, 34% African American, 31% White, 19% Latino). In multivariate models, TA participants (vs. non-TA participants) showed higher electronically monitored [85.3% vs. 70.7% of doses taken; b(SE)=13.16(5.55), p<.05] and self-reported [91.1% vs. 75.0%; b(SE)=11.60(5.65), p<.05] adherence; utilized more social service programs [Ms = 5.2 vs. 3.4; b(SE)=1.97(0.48), p<.0001]; and had fewer unmet social-service needs [Ms = 1.8 vs. 2.7; b(SE)=−1.06(0.48), p<.05]. Findings suggest the need for a randomized controlled trial of TA.
DOI: 10.1097/qai.0b013e3181ab6d48
发表时间: 2009-10-01
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者:
Oh DL;Sarafian F;Silvestre A;Brown T;Jacobson L;Badri S;Detels R
通讯作者: Detels R
DOI: 10.1089/apc.2008.0262
发表时间: 2009-09-01
影响因子: 4.9
作者:
Gardner, Lytt I.;Marks, Gary;del Rio, Carlos
通讯作者: del Rio, Carlos
DOI: 10.1097/00126334-200304010-00009
发表时间: 2003-04-01
影响因子: 3.6
作者:
Giordano, TP;White, AC;Visnegarwala, F
通讯作者: Visnegarwala, F
DOI: 10.1080/0954012021000009665
发表时间: 2002-08-01
影响因子: 1.7
作者:
Chan, D;Absher, D;Sabatier, S
通讯作者: Sabatier, S
DOI: 10.1097/00005650-199912000-00010
发表时间: 1999-12-01
期刊: MEDICAL CARE
影响因子: 3
作者:
Cunningham, WE;Andersen, RM;Shapiro, MF
通讯作者: Shapiro, MF